Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00473187
Status:
UNKNOWN
Last Update Posted:
2007-05-14
First Post:
2007-05-11
Brief Title:
Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
Sponsor:
University of Rostock
Organization:
University of Rostock
Study Overview
Official Title:
Effects of Growth Hormone Treatment on Body Proportions and Final Height Among Small Children With X-Linked Hypophosphatemic Rickets
Status:
UNKNOWN
Status Verified Date:
2007-05
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
X-linked hypophosphatemic rickets XLH is characterized by rickets disproportionate short stature impaired renal phosphate reabsorption and vitamin D metabolism Despite oral phosphate and vitamin D treatment most children with XLH demonstrate reduced adult height The main objective of the study is to determine the beneficial effects of recombinant human growth hormone rhGH therapy on body proportions after 36 month in these patients Secondary objective is to monitor side effects of the therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None